MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$38,770K
Free Cash flow
$60,677K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Stock-based compensation, net of...
Deferred revenue
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net loss
-295,275
-345,065
-442,746
-452,551
Depreciation and amortization
29,556
22,089
13,910
7,620
Net accretion of discounts on marketable securities
22,300
37,766
42,505
8,891
Amortization of debt issuance costs
3,839
3,836
3,813
3,799
Amortization of deferred contract acquisition costs
58,310
54,258
45,888
37,339
Non-cash operating lease costs
4,300
3,966
3,992
8,608
Lease abandonment charges
0
0
15,667
-
Common stock charitable donation expense
-
-
0
0
Stock-based compensation, net of amounts capitalized
397,325
395,660
349,833
277,656
Deferred income taxes
-18,699
277
1,889
-237
Other
-5,686
-3,370
-2,358
-1,384
Accounts receivable
79,718
86,562
53,593
42,080
Deferred contract acquisition costs
71,853
53,246
61,354
62,801
Prepaid expenses and other assets
25,394
-844
10,387
17,850
Accounts payable
13,466
127
-14,452
13,580
Accrued expenses and other liabilities
-15,512
25,639
61,333
9,948
Operating lease liabilities
-8,894
-10,140
-7,479
-9,209
Deferred revenue
89,437
56,173
30,176
76,352
Net cash provided by (used in) operating activities
64,274
33,460
-103,657
-157,333
Capitalization of internal-use software costs
22,558
21,404
17,845
10,334
Purchases of marketable securities
1,638,898
1,539,716
1,586,693
2,051,908
Sales of marketable securities
6,144
15,311
-
0
Maturities of marketable securities
1,474,654
1,591,164
1,578,323
1,200,558
Purchases of investments in privately-held companies
750
2,250
-
-
Purchases of property and equipment
3,597
2,567
2,834
4,121
Cash paid for business combinations, net of cash acquired
0
115,516
55,802
-
Other
-
-
0
0
Net cash used in investing activities
-185,005
-74,978
-84,851
-865,805
Proceeds from initial public offering, net of underwriting discounts and commissions
-
-
0
0
Proceeds from issuance of common stock upon exercise of vested options
57,260
55,836
73,919
42,461
Proceeds from issuance of common stock upon early exercise of unvested options
-
0
0
416
Repurchases of unvested common stock
0
0
-
789
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
-
-
-
0
Repurchases of unvested common stock
-
-
255
-
Payments of deferred offering costs
-
-
0
0
Proceeds from convertible senior notes, net of issuance costs
-
-
0
-786
Payments for purchase of capped calls
-
-
0
0
Payments of debt issuance costs for convertible senior notes
-
0
-
-
Proceeds from issuance of common stock under employee stock purchase plan
23,926
23,970
28,708
40,939
Net cash provided by financing activities
81,186
79,806
102,372
82,241
Effect of exchange rate changes on cash and cash equivalents
775
-2,069
116
-4
Net (decrease) increase in cash and cash equivalents
-38,770
36,219
-86,020
-940,901
Cash and cash equivalents at beginning of period
385,980
349,761
435,781
1,376,682
Cash and cash equivalents at end of period
347,210
385,980
349,761
435,781
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock upon...
$57,260K
(2.55%↑ Y/Y)
Proceeds from issuance of
common stock under...
$23,926K
(-0.18%↓ Y/Y)
Stock-based compensation,
net of amounts...
$397,325K
(0.42%↑ Y/Y)
Deferred revenue
$89,437K
(59.22%↑ Y/Y)
Amortization of deferred
contract acquisition...
$58,310K
(7.47%↑ Y/Y)
Depreciation and
amortization
$29,556K
(33.80%↑ Y/Y)
Accounts payable
$13,466K
(10503.15%↑ Y/Y)
Other
-$5,686K
(-68.72%↓ Y/Y)
Non-cash operating lease
costs
$4,300K
(8.42%↑ Y/Y)
Amortization of debt issuance
costs
$3,839K
(0.08%↑ Y/Y)
Net cash provided by
financing activities
$81,186K
(1.73%↑ Y/Y)
Net cash provided by
(used in) operating...
$64,274K
(92.09%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$775K
(137.46%↑ Y/Y)
Canceled cashflow
$537,645K
Net (decrease)
increase in cash and cash...
-$38,770K
(-207.04%↓ Y/Y)
Canceled cashflow
$146,235K
Maturities of marketable
securities
$1,474,654K
(-7.32%↓ Y/Y)
Sales of marketable
securities
$6,144K
(-59.87%↓ Y/Y)
Net loss
-$295,275K
(14.43%↑ Y/Y)
Accounts receivable
$79,718K
(-7.91%↓ Y/Y)
Deferred contract
acquisition costs
$71,853K
(34.95%↑ Y/Y)
Prepaid expenses and
other assets
$25,394K
(3108.77%↑ Y/Y)
Net accretion of
discounts on marketable...
$22,300K
(-40.95%↓ Y/Y)
Deferred income taxes
-$18,699K
(-6850.54%↓ Y/Y)
Accrued expenses and
other liabilities
-$15,512K
(-160.50%↓ Y/Y)
Operating lease
liabilities
-$8,894K
(12.29%↑ Y/Y)
Net cash used in
investing activities
-$185,005K
(-146.75%↓ Y/Y)
Canceled cashflow
$1,480,798K
Purchases of marketable
securities
$1,638,898K
(6.44%↑ Y/Y)
Capitalization of internal-use
software costs
$22,558K
(5.39%↑ Y/Y)
Purchases of property and
equipment
$3,597K
(40.12%↑ Y/Y)
Purchases of investments
in privately-held...
$750K
(-66.67%↓ Y/Y)
Buy us a coffee
Confluent, Inc. (CFLT)
Confluent, Inc. (CFLT)